0
     

Report Added
Report already added
Global Gynecology Drugs Market, By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2027

Global Gynecology Drugs Market, By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2027

The global gynecology drugs market was valued at USD14139.56 million in 2021 and is expected to grow at a steady CAGR of 8.64% in the forecast period, 2023-2027, to reach USD21395.67 million by 2027. The market is driven by the increased incidences of gynecological diseases and the rise in the elderly female population. Also, the high-end investments by the public and private players in research and development activities to improve the effectiveness of drugs and eliminate the side effects are expected to create lucrative growth opportunities for the global gynecology drugs market in the forecast period.
The rise in the female old age population is expected to fuel the demand for gynecology drugs as they are more prone and are at higher risk of getting affected by gynecological disorders. According to the World Population Prospects in 2021, about 9.5% of females above the age group of 60 years are vulnerable to getting affected by gynecological disorders. The growing old-age population is expected to fuel the demand for the global gynecology drugs market in the forecast period.
The global gynecology drugs market is segmented into therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on regional distribution, the North American region dominated the market in 2021 and held 35.09% of the overall market share. The presence of major market players and well-developed healthcare infrastructure are the primary drivers for the gynecology drugs market. Also, the increased prevalence of breast cancer, menopausal disorders, busy lifestyles, and high stress in women is accelerating the demand for gynecology drugs.
Major companies operating in the global gynecology market are Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals, amongst others.

Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027

Objective of the Study:
•To analyze the historical growth and the market size of the global gynecology drugs market from 2017 to 2021.
•To estimate and forecast the market size of the global gynecology drugs market from 2023 to 2027 and growth rate until 2027.
•To classify and forecast the global gynecology drugs market is divided into therapeutics, indication, distribution channel, regional distribution, and competitive landscape.
•To identify drivers and challenges for the global gynecology drugs market.
•To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global gynecology drugs market.
•To conduct pricing analysis for the global gynecology drugs market.
•To identify and analyze the profile of leading players operating in global gynecology drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading gynecology drugs manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the gynecology drugs manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the gynecology drugs manufacturers, distribution channels and presence of all major players operating in the global gynecology drugs market all over the world.
TechSci Research calculated the global gynecology drugs market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
•Gynecology drugs manufacturers/ suppliers/ distributors
•Government bodies such as regulating authorities and policy makers
•Organizations, forums, and alliances related to gynecology drugs
•Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as gynecology drugs manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.


Report Scope:

In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Gynecology Drugs Market, By Therapeutics:
oNon-Hormonal Therapy
oHormonal Therapy
•Gynecology Drugs Market, By Indication:
oContraception
oGynecology Infections
oFemale Infertility
oPostmenopausal disorders
oPolycystic Ovary Syndrome
oOsteoporosis
oGynecology Cancers
oEndometriosis
oOthers (Urogenital Malformation, UTI & others)
•Gynecology Drugs Market, By Distribution Channel:
oRetail Pharmacies
oHospital Pharmacies
oOnline Pharmacies
•Gynecology Drugs Market, By Region:
oNorth America
United States
Canada
Mexico
oEurope
Germany
France
United Kingdom
Italy
Spain
oAsia-Pacific
China
Japan
India
Australia
South Korea
oSouth America
Brazil
Argentina
Colombia
oMiddle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).
Table of Contents

1.Product Overview
2.Research Methodology
3.Executive Summary
4.Voice of Customer
4.1.Brand Awareness
4.2.Factors Affecting Purchase Decision
4.3.Product Preference, By Therapeutics
5.Impact of COVID-19 on Global Gynecology Drugs Market
6.Global Gynecology Drugs Market Outlook
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.By Therapeutics (Non-Hormonal Therapy vs Hormonal Therapy)
6.2.2.By Indication (Contraception, Gynecology infections, Female infertility, Postmenopausal Disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others)
6.2.3.By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online Pharmacies)
6.2.4.By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.5.By Company (2021)
6.3.Product Market Map
7.North America Gynecology Drugs Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Therapeutics
7.2.2.By Indication
7.2.3.By Distribution Channel
7.2.4.By Country
7.3.North America: Country Analysis
7.3.1.United States Gynecology Drugs Market Outlook
7.3.1.1.Market Size & Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share & Forecast
7.3.1.2.1.By Therapeutics
7.3.1.2.2.By Indication
7.3.1.2.3.By Distribution Channel
7.3.2.Canada Gynecology Drugs Market Outlook
7.3.2.1.Market Size & Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share & Forecast
7.3.2.2.1.By Therapeutics
7.3.2.2.2.By Indication
7.3.2.2.3.By Distribution Channel
7.3.3.Mexico Gynecology Drugs Market Outlook
7.3.3.1.Market Size & Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share & Forecast
7.3.3.2.1.By Therapeutics
7.3.3.2.2.By Indication
7.3.3.2.3.By Distribution Channel
8.Europe Gynecology Drugs Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Therapeutics
8.2.2.By Indication
8.2.3.By Distribution Channel
8.2.4.By Country
8.3.Europe: Country Analysis
8.3.1.Germany Gynecology Drugs Market Outlook
8.3.1.1.Market Size & Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share & Forecast
8.3.1.2.1.By Therapeutics
8.3.1.2.2.By Indication
8.3.1.2.3.By Distribution Channel
8.3.2.France Gynecology Drugs Market Outlook
8.3.2.1.Market Size & Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share & Forecast
8.3.2.2.1.By Therapeutics
8.3.2.2.2.By Indication
8.3.2.2.3.By Distribution Channel
8.3.3.United Kingdom Gynecology Drugs Market Outlook
8.3.3.1.Market Size & Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share & Forecast
8.3.3.2.1.By Therapeutics
8.3.3.2.2.By Indication
8.3.3.2.3.By Distribution Channel
8.3.4.Italy Gynecology Drugs Market Outlook
8.3.4.1.Market Size & Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share & Forecast
8.3.4.2.1.By Therapeutics
8.3.4.2.2.By Indication
8.3.4.2.3.By Distribution Channel
8.3.5.Spain Gynecology Drugs Market Outlook
8.3.5.1.Market Size & Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share & Forecast
8.3.5.2.1.By Therapeutics
8.3.5.2.2.By Indication
8.3.5.2.3.By Distribution Channel
9.Asia Pacific Gynecology Drugs Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Therapeutics
9.2.2.By Indication
9.2.3.By Distribution Channel
9.2.4.By Country
9.3.Asia Pacific: Country Analysis
9.3.1.China Gynecology Drugs Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.By Therapeutics
9.3.1.2.2.By Indication
9.3.1.2.3.By Distribution Channel
9.3.2.Japan Gynecology Drugs Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.By Therapeutics
9.3.2.2.2.By Indication
9.3.2.2.3.By Distribution Channel
9.3.3.India Gynecology Drugs Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.By Therapeutics
9.3.3.2.2.By Indication
9.3.3.2.3.By Distribution Channel
9.3.4.Australia Gynecology Drugs Market Outlook
9.3.4.1.Market Size & Forecast
9.3.4.1.1.By Value
9.3.4.2.Market Share & Forecast
9.3.4.2.1.By Therapeutics
9.3.4.2.2.By Indication
9.3.4.2.3.By Distribution Channel
9.3.5.South Korea Gynecology Drugs Market Outlook
9.3.5.1.Market Size & Forecast
9.3.5.1.1.By Value
9.3.5.2.Market Share & Forecast
9.3.5.2.1.By Therapeutics
9.3.5.2.2.By Indication
9.3.5.2.3.By Distribution Channel
10.South America Gynecology Drugs Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Therapeutics
10.2.2.By Indication
10.2.3.By Distribution Channel
10.2.4.By Country
10.3.South America: Country Analysis
10.3.1.Brazil Gynecology Drugs Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.By Therapeutics
10.3.1.2.2.By Indication
10.3.1.2.3.By Distribution Channel
10.3.2.Argentina Gynecology Drugs Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.By Therapeutics
10.3.2.2.2.By Indication
10.3.2.2.3.By Distribution Channel
10.3.3.Colombia Gynecology Drugs Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.By Therapeutics
10.3.3.2.2.By Indication
10.3.3.2.3.By Distribution Channel
11.Middle East and Africa Gynecology Drugs Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Therapeutics
11.2.2.By Indication
11.2.3.By Distribution Channel
11.2.4.By Country
11.3.Middle East and Africa: Country Analysis
11.3.1.South Africa Gynecology Drugs Market Outlook
11.3.1.1.Market Size & Forecast
11.3.1.1.1.By Value
11.3.1.2.Market Share & Forecast
11.3.1.2.1.By Therapeutics
11.3.1.2.2.By Indication
11.3.1.2.3.By Distribution Channel
11.3.2.Saudi Arabia Gynecology Drugs Market Outlook
11.3.2.1.Market Size & Forecast
11.3.2.1.1.By Value
11.3.2.2.Market Share & Forecast
11.3.2.2.1.By Therapeutics
11.3.2.2.2.By Indication
11.3.2.2.3.By Distribution Channel
11.3.3.UAE Gynecology Drugs Market Outlook
11.3.3.1.Market Size & Forecast
11.3.3.1.1.By Value
11.3.3.2.Market Share & Forecast
11.3.3.2.1.By Therapeutics
11.3.3.2.2.By Indication
11.3.3.2.3.By Distribution Channel
12.Market Dynamics
12.1.Drivers
12.2.Challenges
13.Market Trends and Developments
14.Competitive Landscape
14.1.Company profiles
14.1.1.Eli Lilly and Company Ltd.
14.1.2.Pfizer Inc.
14.1.3.Merck & Co., Inc.
14.1.4.Amgen Inc.
14.1.5.AstraZeneca Plc
14.1.6.F. Hoffmann-La Roche Ltd.
14.1.7.Allergan Plc.
14.1.8.Bayer AG
14.1.9.Abbott Laboratories Ltd.
14.1.10.AbbVie Inc.
14.1.11.GlaxoSmithKline Plc
14.1.12.Novartis Ltd.
14.1.13.Lupin Pharmaceuticals, Inc.
14.1.14.Johnson and Johnson Inc.
14.1.15.Sanofi SA
15.Strategic Recommendations

Report Title: Global Gynecology Drugs Market, By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW